2019
DOI: 10.3390/jcm8111795
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Kidney Disease: The Silent Epidemy

Abstract: Numerous observations suggest that chronic kidney disease (CKD) is an epidemic condition [...]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 32 publications
0
15
0
1
Order By: Relevance
“…Chronic kidney disease (CKD) is associated with poor prognosis [ 1 ]. At the same time in patients with atrial fibrillation (AF) impaired renal function is independently related to stroke or systemic embolism [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Chronic kidney disease (CKD) is associated with poor prognosis [ 1 ]. At the same time in patients with atrial fibrillation (AF) impaired renal function is independently related to stroke or systemic embolism [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Many metabolic abnormalities may promote the development of CKD. Preclinical examination has great advantages in preventing CKD from progressing to end-stage renal disease (ESRD) [11]. The present study aimed to describe distribution characteristics of four renal function indicators in the population, including CysC, UA, Cr and UN.…”
Section: Discussionmentioning
confidence: 99%
“…Early identi cation and treatment of CKD can help prevent or reduce the risk for CKD-related complications [6]. Indeed, a decline in renal function may lead to the accumulation of toxins and have harmful effects on various metabolic pathways, including the progression of in ammation and kidney damage [11]. Thus, it is necessary to measure and monitor renal function of the population.…”
Section: Introductionmentioning
confidence: 99%
“…Its prevalence is increasing dramatically, and it threatens human health and quality of life. Currently, about 8–10% of the world's population has a certain degree of CKD and is the 16th most frequent cause of mortality each year 1 , 2 . Unfortunately, the increasing cost of treating CKD and its complications has placed a considerable economic burden on health care systems worldwide 3 .…”
Section: Introductionmentioning
confidence: 99%
“…Unfortunately, the increasing cost of treating CKD and its complications has placed a considerable economic burden on health care systems worldwide 3 . However, in the early and middle stages of CKD, patients generally do not exhibit any noticeable signs or symptoms 1 . The current diagnostic biomarkers (serum creatinine and urine albumin) are not enough to predict the development of CKD.…”
Section: Introductionmentioning
confidence: 99%